We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Brain Stem Cells Produce Insulin

By Biotechdaily staff writers
Posted on 13 May 2005
Researchers have been able to coax stem cells from the brain to mature into cells that can produce insulin and release it when sugar is added to the environment. More...
This feat could lead to new ways of transplanting insulin-producing cells into diabetics.

Because embryonic stem cells are difficult to work with in a laboratory and most existing human embryonic stem cells lines are contaminated and cannot be transplanted into humans, an alternative was sought by Seung Kim, M.D., Ph.D., assisstant professor of developmental biology at the Stanford University School of Medicine (Palo Alto, CA).

Dr. Kim thought that human neural stem cells might work. "When you look at islet cells you realize that they resemble neurons,” he noted. Like neurons, islet cells respond to external signals by changing their electrical properties and releasing packages of proteins. In the case of islets, that protein is insulin. In fact, the cells that produce insulin and regulate sugar in fruit flies are neurons.

Working with the cells in a lab dish, Dr. Kim and postdoctoral fellow Yuichi Hori, M.D., Ph.D., added a cocktail of chemicals in a sequence they knew might prod the stem cells to mature into insulin-producing cells. The result was a dish full of cells that could produce insulin and release it in response to sugar being added. These cells did not perfectly mimic human islet cells. They made some, but not all, proteins normally made by islet cells and they continued to make some proteins found in neurons.

Dr. Kim then transplanted the cells into a cavity in the kidneys of mice. When the blood sugar went up in these mice, the cells released insulin. After four weeks, the cells were still alive and producing insulin. Although the amount of insulin produced was not enough to treat diabetes, the work is a first step toward that eventual goal. Dr. Kim is the lead author of a paper describing the project, published in the April 26, 2005, issue of PLoS Medicine.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Slide Scanner System
NanoZoomer S540MD
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.